Immunomedics Reports Second Quarter 2019 Results and Provides Corporate Update

    NEXT STORY
    Radius Health Announces Second Quarter 2019 Operating Results
    PREV STORY
    Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

    author_avatar
    NASDAQ Market News

    MDxHealth Provides First Quarter 2018

    author_avatar
    NASDAQ Market News

    Tucatinib Data in Multiple Tumor Types Presented at the European Society for Medical Oncology (ESMO) 2017 Congress

    Results from Pooled Analysis Support the Potential Utility of Tucatinib for Patients with HER2+ ...

    author_avatar
    NASDAQ Market News